Category WHO

Updated List Of Geneva Delegates Responsible For IP

There are many, many committees, councils, panels, meetings, receptions, conferences, assemblies - not to mention countless private lunches, coffees and other contacts - during the year in Geneva that address policy issues related to intellectual property, innovation, research & development and the like. Intellectual Property Watch provides an indispensable, up-to-date list of who you need to talk to when you want to get the message across or follow the action.

A Comprehensive And Fair Solution To The Price Of Medicines

WHO's Marie-Paule Kieny writes: Amid public outcry, political battles and media articles, no one seems to understand how, exactly, medicines prices are set. For years, pharmaceutical research companies have cited the large investment of time and resources that go into bringing a drug to market. More recently, they argue that their medicines are actually saving money by preventing expensive medical interventions like surgery and hospitalization.

But whatever the argument used, the price setting mechanisms for commodities that are inextricably linked to people’s health and survival must be made more transparent so that we can, as a global community, devise effective solutions.